Molecular Neurobiology Of Alzheimer Disease.pdf

Molecular Neurobiology of Alzheimer Disease and

Related Disorders

To Megumi Takeda (September 12, 1957 – February 4, 2002)

Molecular Neurobiology

of Alzheimer Disease and

Related Disorders

Editors

Masatoshi Takeda Osaka

Toshihisa Tanaka Osaka

Ramón Cacabelos Coru ~ a

140 figures, 72 in color, and 18 tables, 2004

Basel · Freiburg · Paris · London · New York ·

Bangalore · Bangkok · Singapore · Tokyo · Sydney

Prof. Masatoshi Takeda

Department of Psychiatry and

Behavioral Proteomics

Osaka University

Graduate School of Medicine

Osaka, Japan

Dr. Toshihisa Tanaka

Department of Psychiatry and

Behavioral Proteomics

Osaka University

Graduate School of Medicine

Osaka, Japan

Prof. Ramón Cacabelos

EuroEspes Biomedical Research Center

Institute for CNS Disorders

Bergondo, Coruña

Library of Congress Cataloging-in-Publication Data

Molecular neurobiology of Alzheimer disease and related disorders / editors, Masatoshi Takeda,

Toshihisa Tanaka, Ramón Cacabelos

p. ; cm.

Includes bibliographical references and index.

ISBN 3–8055–7603–X (hard cover)

1. Alzheimer’s disease–Molecular aspects. 2. Molecular neurobiology. I. Takeda,

Masatoshi, 1949-. II. Tanaka, Toshihisa. III. Cacabelos, Ramón.

[DNLM: 1. Alzheimer Disease–metabolism. 2. Alzheimer Disease–physiopathology. 3.

Alzheimer Disease–genetics. 4. Neurobiology. WT 155 M7183 2003]

RC523.M663 2003

616.8 3107–dc22

2003055886

Bibliographic Indices. This publication is listed in bibliographic services, including Current Contents ® and

Index Medicus.

Drug Dosage. The authors and the publisher have exerted every effort to ensure that drug selection and

dosage set forth in this text are in accord with current recommendations and practice at the time of publication.

However, in view of ongoing research, changes in government regulations, and the constant flow of information

relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for

any change in indications and dosage and for added warnings and precautions. This is particularly important

when the recommended agent is a new and/or infrequently employed drug.

utilized in any form or by any means electronic or mechanical, including photocopying, recording, microcopying,

or by any information storage and retrieval system, without permission in writing from the publisher.

www.karger.com

Printed in Switzerland on acid-free paper by Reinhardt Druck, Basel

ISBN 3–8055–7603–X

Plik z chomika:

Inne pliki z tego folderu:

Inne foldery tego chomika: